The report from ASFA COVID‐19 taskforce : Considerations and prioritization on apheresis procedures during the SARS‐CoV‐2 coronavirus disease ( COVID‐19) pandemic
Abstract Since vaccination for SARS‐CoV‐2 coronavirus started, the trajectory of patient numbers infected with the virus has improved once; however, variants of SARS‐CoV‐2 have emerged and more people have been infected; therefore, pandemic status is still far from resolution. Government and social efforts to prevent coronavirus infection continue in most states in the US and globally even after the Centers for Disease Control and Prevention declared some restriction relief for fully vaccinated people in March 2021. Healthcare institutions and various professional organizations have developed guidelines or policies to prevent the spread of these coronaviruses in the setting of apheresis. In this report, the issues that apheresis services may encounter under the current COVID‐19 (SARS‐CoV‐2 coronavirus disease) pandemic will be discussed with potential strategies that can be adapted for efficient and optimum use of apheresis resources..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Journal of Clinical Apheresis - 36(2021), 6, Seite 878-881 |
| Beteiligte Personen: |
Yamada, Chisa [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2021 Wiley Periodicals LLC |
|---|
| Umfang: |
4 |
|---|
| doi: |
10.1002/jca.21939 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY007886802 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY007886802 | ||
| 003 | DE-627 | ||
| 005 | 20230307173351.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/jca.21939 |2 doi | |
| 028 | 5 | 2 | |a JCA_JCA21939.xml |
| 035 | |a (DE-627)WLY007886802 | ||
| 035 | |a (WILEY)JCA21939 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.86 |2 bkl | ||
| 100 | 1 | |a Yamada, Chisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The report from ASFA COVID‐19 taskforce |b Considerations and prioritization on apheresis procedures during the SARS‐CoV‐2 coronavirus disease ( COVID‐19) pandemic |
| 264 | 1 | |c 2021 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 Wiley Periodicals LLC | ||
| 520 | |a Abstract Since vaccination for SARS‐CoV‐2 coronavirus started, the trajectory of patient numbers infected with the virus has improved once; however, variants of SARS‐CoV‐2 have emerged and more people have been infected; therefore, pandemic status is still far from resolution. Government and social efforts to prevent coronavirus infection continue in most states in the US and globally even after the Centers for Disease Control and Prevention declared some restriction relief for fully vaccinated people in March 2021. Healthcare institutions and various professional organizations have developed guidelines or policies to prevent the spread of these coronaviruses in the setting of apheresis. In this report, the issues that apheresis services may encounter under the current COVID‐19 (SARS‐CoV‐2 coronavirus disease) pandemic will be discussed with potential strategies that can be adapted for efficient and optimum use of apheresis resources. | ||
| 700 | 1 | |a Hofmann, Jan C. |4 aut | |
| 700 | 1 | |a Witt, Volker |4 aut | |
| 700 | 1 | |a Gupta, Gaurav K. |4 aut | |
| 700 | 1 | |a Winters, Jeffrey L. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Clinical Apheresis |g 36(2021), 6, Seite 878-881 |w (DE-627)WLY007885288 |x 10981101 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2021 |g number:6 |g pages:878-881 |g extent:4 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.86 |q ASE |
| 951 | |a AR | ||
| 952 | |d 36 |j 2021 |e 6 |h 878-881 |g 4 | ||